Torrey Pines Law Group's founder, Kevin Buckley, has been a biotech patent attorney for more than 20 years. Prior to becoming a patent attorney, Kevin was a biochemist for many years at UC San Diego as well as in industry on the Torrey Pines mesa where he studied immuno-oncology, RNA-derived therapeutics, and bioinformatics systems.
His experience has provided both his clients and his colleagues valuable insight into solving complex legal problems related to:
Torrey Pines Law Group's clients are on the leading edge of biotechnology innovation. Those biotechnology innovations include technologies that affect our daily lives such as personalized medicine, biosensors, and diagnostics. Kevin has also helped advance more controversial technologies including "pharming," regenerative medicine, embryonic stem cell research, pluripotent stem cells, and gene editing.
One can imagine that the entire body of biotechnology law that affects this patchwork of technologies is as varied and far-reaching as the underlying technologies themselves. Biotechnology law has become a continuously adaptive body of law that evolves with the pace of biotechnology development, and because biotechnology law is also influenced by business cycles and the market, the most effective way to understand biotechnology law is by studying its evolution at the intersection of law, business, and science. Legal issues at this intersection include intellectual property (especially patents), federal regulation, research funding, federal approval of products for human use, privacy issues, and international issues, among many other unique legal issues.
The IP attorneys, patent lawyers, engineers, scientists, and patent agents at Torrey Pines Law Group have also worked in a variety of biotechnology industries and have assisted with commercializing, researching, and developing technologies including: